Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Is interleukin-6 receptor blockade the Holy Grail for inflammatory diseases?
M A Febbraio, S Rose-John,
B K Pedersen
49
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Is interleukin-6 receptor blockade the Holy Grail for inflammatory diseases?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Interleukin-6 Receptors
100%
tocilizumab
71%
Rheumatoid Arthritis
63%
Hyperlipidemias
25%
United States Food and Drug Administration
25%
Crohn Disease
24%
Weight Gain
23%
Interleukin-6
19%
Monoclonal Antibodies
18%
Inflammation
14%
Therapeutics
8%
Neoplasms
8%